Resmed executives will speak at the Bank of America Global Healthcare Conference on September 23, 2025, in London.
Quiver AI Summary
Resmed announced that CEO Mick Farrell and CMO Dr. Carlos Nunez will present at the Bank of America Global Healthcare Conference 2025 in London on September 23, 2025, at approximately 1:20 p.m. British Summer Time. The event will be available via a live audio-only webcast, with a replay accessible for 30 days after the event. Resmed focuses on developing innovative health technologies to improve the lives of people worldwide by enhancing home healthcare through AI-powered solutions and cloud-connected devices. Their goal is to enable individuals to achieve better sleep and breathing at home.
Potential Positives
- Resmed's participation in the Bank of America Global Healthcare Conference highlights its presence in the healthcare sector and provides an opportunity to showcase its innovative technologies to potential investors and partners.
- The announcement emphasizes Resmed's commitment to advancing healthcare technology, particularly in AI and home healthcare solutions, which can enhance its market position and attract interest from stakeholders.
- By offering a live audio-only webcast and subsequent replay, Resmed demonstrates transparency and accessibility to its investors, fostering better communication and engagement with the investment community.
- The company's mission to empower individuals through innovative health technologies underscores its potential for growth in a market focused on personalized and effective healthcare solutions.
Potential Negatives
- None
FAQ
When is the Bank of America Global Healthcare Conference 2025?
The conference will be on Tuesday, September 23, 2025, starting at approximately 1:20 p.m. (British Summer Time).
Who will represent Resmed at the conference?
Mick Farrell, chairman and CEO, and Dr. Carlos Nunez, chief medical officer, will present at the conference.
How can I access the live webcast of the conference?
You can access the live, audio-only webcast by visiting https://investor.resmed.com.
Will there be a replay of the webcast available?
Yes, the audio-only webcast replay will be available approximately 24 hours after the live event and accessible for 30 days.
What is Resmed’s mission?
Resmed's mission is to create innovative technologies for better sleep and breathing, helping people live happier, healthier lives.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$RMD Congressional Stock Trading
Members of Congress have traded $RMD stock 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $RMD stock by members of Congress over the last 6 months:
- REPRESENTATIVE KELLY MORRISON has traded it 5 times. They made 0 purchases and 5 sales worth up to $75,000 on 06/04, 04/28.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$RMD Insider Trading Activity
$RMD insiders have traded $RMD stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $RMD stock by insiders over the last 6 months:
- MICHAEL J. FARRELL (Chief Executive Officer) has made 0 purchases and 6 sales selling 48,054 shares for an estimated $12,162,657.
- BRETT SANDERCOCK (Chief Financial Officer) has made 0 purchases and 6 sales selling 15,527 shares for an estimated $4,006,548.
- PETER C FARRELL has made 0 purchases and 4 sales selling 6,945 shares for an estimated $1,660,058.
- JOHN HERNANDEZ sold 2,575 shares for an estimated $739,289
- WITTE JAN DE sold 2,000 shares for an estimated $486,940
- MICHAEL J RIDER (Global General Counsel) has made 0 purchases and 4 sales selling 221 shares for an estimated $55,314.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RMD Hedge Fund Activity
We have seen 462 institutional investors add shares of $RMD stock to their portfolio, and 453 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 1,479,378 shares (-35.7%) from their portfolio in Q2 2025, for an estimated $381,679,524
- GAMMA INVESTING LLC removed 729,713 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $188,265,954
- NORGES BANK added 669,170 shares (+129.0%) to their portfolio in Q2 2025, for an estimated $172,645,860
- OVERSEA-CHINESE BANKING CORP LTD removed 547,532 shares (-92.7%) from their portfolio in Q2 2025, for an estimated $141,263,256
- MARSHALL WACE, LLP removed 543,857 shares (-97.7%) from their portfolio in Q2 2025, for an estimated $140,315,106
- CONGRESS ASSET MANAGEMENT CO removed 484,773 shares (-99.0%) from their portfolio in Q2 2025, for an estimated $125,071,434
- CITADEL ADVISORS LLC added 328,864 shares (+853.5%) to their portfolio in Q2 2025, for an estimated $84,846,912
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RMD Analyst Ratings
Wall Street analysts have issued reports on $RMD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 08/01/2025
- UBS issued a "Buy" rating on 08/01/2025
- Mizuho issued a "Outperform" rating on 08/01/2025
- JP Morgan issued a "Overweight" rating on 04/24/2025
- Keybanc issued a "Overweight" rating on 04/24/2025
To track analyst ratings and price targets for $RMD, check out Quiver Quantitative's $RMD forecast page.
$RMD Price Targets
Multiple analysts have issued price targets for $RMD recently. We have seen 8 analysts offer price targets for $RMD in the last 6 months, with a median target of $290.0.
Here are some recent targets:
- Adam Maeder from Piper Sandler set a target price of $270.0 on 08/01/2025
- Jonathan Block from Stifel set a target price of $270.0 on 08/01/2025
- Craig Wong-Pan from RBC Capital set a target price of $300.0 on 08/01/2025
- Laura Sutcliffe from UBS set a target price of $325.0 on 08/01/2025
- Brett Fishbin from Keybanc set a target price of $298.0 on 08/01/2025
- Anthony Petrone from Mizuho set a target price of $290.0 on 08/01/2025
- David Low from JP Morgan set a target price of $290.0 on 04/24/2025
Full Release
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Conference 2025 on Tuesday, September 23, 2025, beginning at approximately 1:20 p.m. (British Summer Time) in London.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com . The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
|
For investors
+1 858.221.3304 [email protected] |
For media
+1 619.510.1281 [email protected] |
|
